key: cord-0936046-e1enfmby
authors: Valley-Omar, Ziyaad; Marais, Gert; Iranzadeh, Arash; Naidoo, Michelle; Korsman, Stephen; Maponga, Tongai; Hussey, Hannah; Davies, Mary-Ann; Boulle, Andrew; Doolabh, Deelan; Laubscher, Mariska; Wojno, Justyna; Deetlefs, JD; Maritz, Jean; Scott, Lesley; Msomi, Nokukhanya; Naicker, Cherise; Tegally, Houriiyah; de Oliveira, Tulio; Bhiman, Jinal; Williamson, Carolyn; Preiser, Wolfgang; Hardie, Diana; Hsiao, Nei-yuan
title: Reduced amplification efficiency of the RNA-dependent-RNA-polymerase target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests
date: 2022-01-18
journal: J Virol Methods
DOI: 10.1016/j.jviromet.2022.114471
sha: aed7b91e7bb1bc5031646ad387ea761ef0e83695
doc_id: 936046
cord_uid: e1enfmby

Routine SARS-CoV-2 surveillance in the Western Cape region of South Africa (January-August 2021) found a reduced RT-PCR amplification efficiency of the RdRp-gene target of the Seegene, Allplex 2019-nCoV diagnostic assay from June 2021 when detecting the Delta variant. We investigated whether the reduced amplification efficiency denoted by an increased RT-PCR cycle threshold value (RΔE) can be used as an indirect measure of SARS-CoV-2 Delta variant prevalence. We found a significant increase in the median RΔE for patient samples tested from June 2021, which coincided with the emergence of the SARS-CoV-2 Delta variant within our sample set. Whole genome sequencing on a subset of patient samples identified a highly conserved G15451A, non-synonymous mutation exclusively within the RdRp gene of Delta variants, which may cause reduced RT-PCR amplification efficiency. While whole genome sequencing plays an important in identifying novel SARS-CoV-2 variants, monitoring RΔE value can serve as a useful surrogate for rapid tracking of Delta variant prevalence.

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

CoV-2 Delta variant prevalence. We found a significant increase in the median R∆E for patient samples tested from June 2021, which coincided with the emergence of the SARS-CoV-2 Delta variant within our sample set. Whole genome sequencing on a subset of patient samples identified a highly conserved G15451A, non-synonymous mutation exclusively within the RdRp gene of Delta variants, which may cause reduced RT-PCR amplification efficiency. While whole genome sequencing plays an important in identifying novel SARS-CoV-2 variants, monitoring R∆E value can serve as a useful surrogate for rapid tracking of Delta variant prevalence.

Severe Acute respiratory Syndrome Coronavirus 2 (SARS-CoV-2); Whole Genome Sequencing (WGS); Variants of Concern (VOCs); Spike (S); Nucleocapsid (N); Envelope by whole genome sequencing (WGS) has played a critical role in identifying and monitoring the dissemination of variants of concern (VOCs) [1, 2] . However, WGS is costly and timeconsuming, and not all countries have the resources to do this at scale to get detailed VOC epidemiological information.

Multiplex reverse transcriptase polymerase chain reaction (RT-PCR)-based diagnostic tests for SARS-CoV-2, which simultaneously amplify and detect multiple SARS-CoV-2 gene targets, such as the Spike (S)-, Nucleocapsid (N)-, Envelope (E)-and RNA-dependent-RNApolymerase (RdRp) genes, are the primary tools used to diagnose cases and define epidemic waves. Current commercial tests were designed to detect ancestral SARS-CoV-2 sequences and have not been optimised for the viral genomic diversity that has subsequently emerged [3] . Despite this, built-in redundancy through detecting multiple gene targets ensures that these assays continue to be effective tools for diagnosing infections by contemporary variants as diagnostic assays do not need to detect all target genes. For example, deletions of amino acids 69 and 70 within the S-gene of SARS-CoV-2 Alpha and Omicron variants was associated with failure to detect this target by some commonly used commercial diagnostic assays (e.g. ThermoFisher TaqPath, Waltham, USA). Fortuitously, because the other targets are largely unaffected, this S-gene target failure (S-GTF) has been used as a convenient surrogate marker for monitoring prevalence of SARS-CoV-2 Alpha variant [4, 5] .

As the Delta variant becomes the predominant VOC across the world, a similar diagnostic RT-PCR-based marker has potential to enable similar rapid epidemiological assessment and

research. An evaluation of routine diagnostic results together with WGS, we show that infection with the Delta variant is associated with reduced RdRp target amplification efficiency and propose that this can be used for tracking the prevalence of this variant.

Routine SARS-CoV-2 diagnostic testing in the South African public health sector, which is used by circa 80% of the population is performed by the National Health Laboratory Service (NHLS). NHLS laboratories also form part of the network for genomic surveillance South Africa (NGS-SA) where a subset of routine diagnostic samples are sequenced as part of the genomic surveillance activities [6] . WGS was performed using either GridION X5 (Oxford Nanopore Technologies, Oxford, United Kingdom) or MiSeq (Illumina, San Diego, USA) sequencing platforms [7] . To ensure accurate clade assignment, we only included sequences with less than 3000 bases missing, no frameshift mutations and no misplaced stop codons. All sequences were deposited on the Global Initiative on Sharing All Influenza Data (GISAID) SARS-CoV-2 sequence repository (https://www.gisaid.org/) (Supplementary Table 1 (Supplementary figure 2) . The diagnostic ability of the R∆E value to identify the Delta variant was evaluated using a receiver operating characteristic (ROC) curve (Supplementary figure 3) . Using a R∆E threshold of > 3.5 cycles we were able to accurately identify Delta variant positive samples within the sample set with 93.6% sensitivity and 89.7% specificity, correctly classifying 90% of cases (Area under the curve (AUC) = 0.9663). When the threshold is increased to 4 and 4.5 cycles, the specificity was improved to 96.5% and 98% respectively but the sensitivity was reduced to 86.7% and 80% respectively.

In this article we show that reduced amplification efficiency of the RdRp gene target of the Seegene, Allplex 2019-nCoV assay can be used as an indirect measure of SARS-CoV-2 Delta variant prevalence in a population. Using the R∆E value could therefore serve as a reliable surrogate for genomic sequencing to approximate the spread of the SARS-CoV-2 Delta variant. While using the R∆E is only a surrogate marker of Delta variant identity, assay Ct values have proven useful in the past to identify Alpha variant prevalence as well as serving as an independent predictor of disease severity [9, 10] . Limitations to our study concern the proprietary nature of the Seegene, Allplex 2019-nCoV assay. We are unable to confirm the exact genomic loci amplified by the assay primers and probes. Evidence including the RdRp target delay in Delta variants from this study, RdRp complete GTF in a minority of Beta variants and confirmation by Seegene that the G15451A mutation in Delta variants leads to a mismatch in the primer binding site, suggest that these diagnostic primers overlap with the WHO-recommended RT-PCR primer sets stemming from Corman et al., 2020 [8] . This study highlights the need for continued monitoring of the efficacy of current commercial SARS- 

New SARS-CoV-2 Variants -Clinical, Public Health, and Vaccine Implications

WHO. Tracking SARS-CoV-2 variants

WHO. WHO inhouse assays

S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Network for Genomic Surveillance in South Africa writing g. A genomics network established to respond rapidly to public health threats in South Africa

Detection of a SARS-CoV-2 variant of concern in South Africa

Detection of 2019 novel coronavirus (2019-nCoV) by realtime RT-PCR. Euro surveillance : bulletin Europeen sur les maladies transmissibles

Clinical infectious diseases : an official publication of the Infectious Diseases Society of

SARS-CoV-2 PCR cycle threshold at hospital admission associated with patient mortality

We gratefully acknowledge the efforts of the staff of the NHLS and University of Cape Town 

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.